These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30344084)

  • 1. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
    Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
    Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for HIV-associated cryptococcal meningitis.
    Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
    Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
    Molloy SF; Kanyama C; Heyderman RS; Loyse A; Kouanfack C; Chanda D; Mfinanga S; Temfack E; Lakhi S; Lesikari S; Chan AK; Stone N; Kalata N; Karunaharan N; Gaskell K; Peirse M; Ellis J; Chawinga C; Lontsi S; Ndong JG; Bright P; Lupiya D; Chen T; Bradley J; Adams J; van der Horst C; van Oosterhout JJ; Sini V; Mapoure YN; Mwaba P; Bicanic T; Lalloo DG; Wang D; Hosseinipour MC; Lortholary O; Jaffar S; Harrison TS;
    N Engl J Med; 2018 Mar; 378(11):1004-1017. PubMed ID: 29539274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings.
    Milani B; Ford N
    S Afr Med J; 2012 Mar; 102(4):196-7. PubMed ID: 22464494
    [No Abstract]   [Full Text] [Related]  

  • 7. Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
    Merry M; Boulware DR
    Clin Infect Dis; 2016 Jun; 62(12):1564-8. PubMed ID: 27009249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
    Yao ZW; Lu X; Shen C; Lin DF
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
    Lofgren S; Abassi M; Rhein J; Boulware DR
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
    Loyse A; Dromer F; Day J; Lortholary O; Harrison TS
    J Antimicrob Chemother; 2013 Nov; 68(11):2435-44. PubMed ID: 23788479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
    Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
    Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
    Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
    Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
    Rajasingham R; Rolfes MA; Birkenkamp KE; Meya DB; Boulware DR
    PLoS Med; 2012; 9(9):e1001316. PubMed ID: 23055838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
    Larsen RA; Bauer M; Thomas AM; Graybill JR
    Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antifungal therapy for cryptococcal meningitis.
    Day JN; Chau TTH; Wolbers M; Mai PP; Dung NT; Mai NH; Phu NH; Nghia HD; Phong ND; Thai CQ; Thai LH; Chuong LV; Sinh DX; Duong VA; Hoang TN; Diep PT; Campbell JI; Sieu TPM; Baker SG; Chau NVV; Hien TT; Lalloo DG; Farrar JJ
    N Engl J Med; 2013 Apr; 368(14):1291-1302. PubMed ID: 23550668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa.
    Miot J; Leong T; Takuva S; Parrish A; Dawood H
    BMC Health Serv Res; 2021 Apr; 21(1):305. PubMed ID: 33823842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating cryptococcal meningitis in people with HIV.
    BMJ; 2013 Apr; 346():f2203. PubMed ID: 23575571
    [No Abstract]   [Full Text] [Related]  

  • 20. An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
    Shapiro AE; Tenforde MW; Chiller TM; Ford N; Rajasingham R
    HIV Med; 2023 Apr; 24(4):507-512. PubMed ID: 36123803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.